These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10664826

  • 1. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R.
    Biol Psychiatry; 2000 Jan 15; 47(2):107-11. PubMed ID: 10664826
    [Abstract] [Full Text] [Related]

  • 2. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar 15; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 3. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb 15; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 4. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct 15; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 5. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
    Kellner M, Muhtz C, Stark K, Yassouridis A, Arlt J, Wiedemann K.
    Psychopharmacology (Berl); 2005 Apr 15; 179(1):310-5. PubMed ID: 15821951
    [Abstract] [Full Text] [Related]

  • 6. Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide?
    Kellner M, Yassouridis A, Hübner R, Baker DG, Wiedemann K.
    Neuropsychobiology; 2003 Apr 15; 47(2):102-8. PubMed ID: 12707494
    [Abstract] [Full Text] [Related]

  • 7. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Apr 15; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 8. Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men.
    Kellner M, Yassouridis A, Hua Y, Wendrich M, Jahn H, Wiedemann K.
    J Psychiatr Res; 2002 Apr 15; 36(1):1-6. PubMed ID: 11755455
    [Abstract] [Full Text] [Related]

  • 9. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr 15; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 10. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep 15; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 11. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 15; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 12. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 15; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 13. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M, Fuertig R, Mack SR, Just S, Sharma V, Wunder A, den Boer J.
    CNS Drugs; 2023 Dec 15; 37(12):1099-1109. PubMed ID: 38019356
    [Abstract] [Full Text] [Related]

  • 14. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J, Koszycki D, Shriqui C.
    Arch Gen Psychiatry; 1991 Jul 15; 48(7):603-10. PubMed ID: 2069490
    [Abstract] [Full Text] [Related]

  • 15. Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man.
    Kellner M, Yassouridis A, Hua Y, Wendrich M, Naber D, Wiedemann K.
    Psychiatry Res; 2002 Aug 05; 111(1):93-6. PubMed ID: 12140124
    [Abstract] [Full Text] [Related]

  • 16. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder.
    Smith MA, Davidson J, Ritchie JC, Kudler H, Lipper S, Chappell P, Nemeroff CB.
    Biol Psychiatry; 1989 Aug 05; 26(4):349-55. PubMed ID: 2548631
    [Abstract] [Full Text] [Related]

  • 17. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr 05; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 18. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D, Torres S, Swain JE, Bradwejn J.
    Psychosom Med; 2005 Apr 05; 67(4):590-5. PubMed ID: 16046372
    [Abstract] [Full Text] [Related]

  • 19. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, Karkanias C.
    Biol Psychiatry; 1992 Nov 15; 32(10):903-12. PubMed ID: 1467375
    [Abstract] [Full Text] [Related]

  • 20. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.
    Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, Westenberg H.
    Arch Gen Psychiatry; 1994 Jun 15; 51(6):486-93. PubMed ID: 8192551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.